BPMC |
Blueprint Medicines Corp |
Nov 20, 2024 |
8 |
-$1.25M |
4 |
Nov 22, 2024 |
Director |
VERV |
Verve Therapeutics, Inc. |
Jun 26, 2024 |
1 |
$0 |
4 |
Jun 28, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Jun 12, 2024 |
2 |
$0 |
4 |
Jun 14, 2024 |
Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Feb 28, 2024 |
7 |
-$161K |
4 |
Feb 29, 2024 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Feb 8, 2024 |
2 |
$0 |
4 |
Feb 12, 2024 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Nov 16, 2023 |
1 |
$94.8K |
4 |
Nov 17, 2023 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Nov 10, 2023 |
1 |
$10.1K |
4 |
Nov 13, 2023 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Jun 29, 2023 |
1 |
$21.6K |
4 |
Jun 29, 2023 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Jun 23, 2023 |
2 |
$46.7K |
4 |
Jun 26, 2023 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Jun 22, 2023 |
1 |
$92.4K |
4 |
Jun 22, 2023 |
Chief Executive Officer, Director |
BPMC |
Blueprint Medicines Corp |
Jun 21, 2023 |
2 |
$5.3K |
4 |
Jun 23, 2023 |
Director |
VERV |
Verve Therapeutics, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Feb 28, 2023 |
7 |
-$111K |
4 |
Mar 1, 2023 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Feb 9, 2023 |
2 |
$0 |
4 |
Feb 13, 2023 |
Chief Executive Officer, Director |
VERV |
Verve Therapeutics, Inc. |
Aug 8, 2022 |
1 |
$0 |
4 |
Aug 9, 2022 |
Director |
VERV |
Verve Therapeutics, Inc. |
Aug 8, 2022 |
0 |
$0 |
3 |
Aug 9, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
Jun 21, 2022 |
2 |
$0 |
4 |
Jun 30, 2022 |
Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Feb 28, 2022 |
7 |
-$137K |
4 |
Feb 28, 2022 |
Chief Executive Officer, Director |
LXRX |
LEXICON PHARMACEUTICALS, INC. |
Feb 10, 2022 |
2 |
$0 |
4 |
Feb 14, 2022 |
Chief Executive Officer, Director |
BPMC |
Blueprint Medicines Corp |
Jun 2, 2021 |
2 |
$0 |
4 |
Jun 4, 2021 |
Director |